New study expands range of potential Alzheimer’s drugs

COVID-19 infection linked to heightened risk of poor cardiovascular health and death
24 October 2022
What’s behind worrying RSV surge in US children’s hospitals?
25 October 2022

New study expands range of potential Alzheimer’s drugs

Alzheimer’s disease is associated with a reduction of insulin receptors in brain microvessels, which may contribute to brain insulin resistance and the formation of amyloid plaques, one of the disease’s hallmarks. That’s according to a study published today in the journal Brain by a team from Université Laval and Rush University Medical Center in Chicago.

Comments are closed.